Potassium binder helps heart failure patients with kidney disease reach full drug doses
A randomised double-blind trial shows the potassium binder sodium zirconium cyclosilicate enabled twice as many patients with chronic kidney disease ...
A randomised double-blind trial shows the potassium binder sodium zirconium cyclosilicate enabled twice as many patients with chronic kidney disease ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.